Intranasally administered S-MGB-364 displays antitubercular activity and modulates the host immune response to Mycobacterium tuberculosis infection. (2022)
Attributed to:
Understanding intrinsically disordered proteins and their potential as new drug targets through novel measurement capabilities
funded by
UKRI FLF
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/jac/dkac001
PubMed Identifier: 35084027
Publication URI: http://europepmc.org/abstract/MED/35084027
Type: Journal Article/Review
Volume: 77
Parent Publication: The Journal of antimicrobial chemotherapy
Issue: 4
ISSN: 0305-7453